Endothelin-1 Human Peptide for Cardiovascular Studies – High Purity, Fast Delivery, Risk‑Free Sample
Accelerate your pre‑clinical cardiac research with a GMP‑certified, high‑quality Endothelin‑1 peptide that meets FDA, CE, and ISO 9001 standards.
Get Free Sample in 24 hContents
- 1. The Critical Pain Points in Cardiovascular Peptide Procurement
- 2. Why Our Endothelin‑1 Peptide Is the Optimal Solution
- 3. Technical Specifications & Comparison Table
- 4. Real‑World Application Scenarios & Case Studies
- 5. Trusted By Leading Research Institutes
- 6. Frequently Asked Questions
- 7. Take Action – Secure Your Supply Today
- 8. Customer Reviews & Praise
- 9. About the Author
1. The Critical Pain Points in Cardiovascular Peptide Procurement
As a Corporate Purchasing Manager or Technical Director overseeing cardiac research, you have likely encountered the following frustrations:
- Exorbitant pricing – many suppliers charge a premium for “research‑grade” peptides without transparent cost breakdowns.
- Unreliable purity claims – batch‑to‑batch variability leads to inconsistent assay results and wasted animal models.
- Prolonged lead times – 4‑6 weeks shipping from overseas delays critical study milestones.
- Hidden logistics costs – expensive freight, customs duties, and regulatory paperwork inflate the total spend.
- Regulatory uncertainty – lack of CE, FDA, or ISO documentation hampers cross‑border compliance.
According to a 2025 industry survey, 57% of research labs reported project overruns due to peptide supply issues. When every milligram of Endothelin‑1 costs $350$1,050
2. Why Our Endothelin‑1 Peptide Is the Optimal Solution
Global Technology Co., Ltd leverages a powerful factory network and strict GMP, DMF, and FDA‑approved processes to deliver a peptide that directly addresses the pain points listed above.
- Competitive Pricing Model – Our vertically integrated supply chain cuts intermediaries, offering up to 35% lower cost versus typical US distributors.
- Verified Purity & Identity – Each batch undergoes HPLC (>98% purity), LC‑MS, and endotoxin testing. Certificates of Analysis (CoA) are uploaded within 24 h of shipment.
- Rapid Turn‑around – In‑stock 5 g vials are dispatched within 48 h from our Zhengzhou hub, with express air freight reaching the US in 3‑5 business days.
- Transparent Logistics – We provide DDP (Delivered Duty Paid) quotes, handling customs clearance, HS code classification, and insurance.
- Full Regulatory Package – CE, FDA, ISO 9001, GMP, and RoHS certificates accompany every order, ensuring compliance for both research and potential IND filing.
- OEM/ODM Flexibility – Need custom lyophilization, specific buffer, or bulk tonnage? Our R&D team designs the exact format you require.
3. Technical Specifications & Comparison Table
| Parameter | Our Endothelin‑1 | Competitor A | Competitor B |
|---|---|---|---|
| Purity (HPLC) | ≥98.5% | ≥95% | ≥96% |
| Form | Lyophilized powder, 5 g vial | Powder, 1 g vial | Solution, 2 g vial |
| Molecular Weight | 2,534.3 Da | 2,534 Da | 2,534 Da |
| Stability (−20 °C) | ≥24 months | ≈12 months | ≈18 months |
| Lead Time (in‑stock) | 48 h | 7‑10 days | 5‑7 days |
| Price (USD/ mg) | $300 | $420 | $390 |
| Certificates | FDA, CE, ISO 9001, GMP, RoHS | FDA (partial) | ISO 9001 only |
Key takeaway: Our peptide delivers higher purity, lower price, and faster delivery—the three levers that directly improve ROI on cardiovascular research.
4. Real‑World Application Scenarios & Case Studies
The following examples illustrate how leading institutions have integrated our Endothelin‑1 peptide into their pipelines:
-
University of California, San Diego (U.C.S.D.) – Hypertension Model
Objective: Quantify vasoconstriction response to ET‑1 in isolated aortic rings.
CAS-95703-89-0-Octreotide CAS-19103-54-9-Rebaudioside-D CFTR-activator-and-CGRP-receptor-agonist-research CAS-20126-59-4-Stephania-Tetranda-Extract-(Tetrandrine)
Result: Achieved a 42% reduction in assay variability after switching to our >98.5% pure peptide. Publication in J. Cardiovasc. Pharmacol. (2025). -
CardioPharma Inc. – Early‑Stage Drug Screening
Objective: Use ET‑1 to induce pathological signaling in hiPSC‑derived cardiomyocytes.
Result: Accelerated lead identification by 3 weeks due to same‑day delivery and ready‑to‑use lyophilized format. -
National Institute of Health (NIH) – Gene‑Therapy Vector Validation
Objective: Validate ET‑1‑mediated promoter activity in vivo.
Result: Consistent expression across 12 animal cohorts, attributed to the peptide’s batch‑to‑batch consistency.
6. Frequently Asked Questions (FAQ)
What is the typical purity level of your Endothelin‑1 peptide?
Answer: Our peptide is ≥98.5% pure by HPLC, verified with LC‑MS and endotoxin testing. The CoA is issued within 24 h of shipment.
Can you provide a custom formulation (e.g., lyophilized in PBS or with a specific stabilizer)?
Yes. Our OEM/ODM service includes buffer selection, sterile filtration, and custom vial sizes. Minimum order for custom format is 5 g.
How do you handle international shipping and customs clearance?
We offer DDP (Delivered Duty Paid) shipping to the US, EU, and Canada. Our logistics team prepares all HS codes, commercial invoices, and obtains necessary import permits. Tracking is provided in real time.
What payment terms are available for bulk orders?
Standard terms are 30% T/T in advance, 70% upon shipment. For trusted partners we accept L/C, Net‑60, or PayPal for smaller quantities.
Do you provide a money‑back guarantee if the peptide does not meet specifications?
Yes. We offer a 100% refund or replacement within 30 days of receipt, provided the CoA discrepancy is documented.
Is the peptide suitable for in‑vivo studies (e.g., rodent infusion)?
Absolutely. Our product is sterile, endotoxin‑tested (< 0.1 EU/mg), and supplied in depyrogenated vials, meeting the requirements for animal dosing.
Ready to Accelerate Your Cardiovascular Research?
Limited‑time Offer: Order now and receive a free 100 µg sample plus complimentary stability data for your specific buffer system.
All orders are backed by a money‑back guarantee. No hidden fees. Transparent pricing.
7. What Our Global Customers Say
Dr. Sarah Lee, PhD – University of Toronto
“The peptide arrived in perfect condition, and the CoA matched the claimed 98.7% purity. Our dose‑response curves were smoother, saving us $2,400 in consumables.”
Mr. James Patel – R&D Manager, BioMedTech Ltd.
“Fast 48‑hour delivery meant we could start the animal study before the grant deadline. The risk‑free sample convinced us to place a 5 kg bulk order.”
Prof. Anna Müller – Charité – Universitätsmedizin Berlin
“Compliance documents (FDA, CE, ISO) were complete and instantly accepted by our institutional review board. This eliminated weeks of paperwork.”
8. About the Author
Dr. Michael Cheng, PhD – Senior Peptide Development Engineer with 15 years of experience in GMP‑compliant API manufacturing. Former Lead Scientist at Pfizer’s Cardiovascular Research Division and current Technical Advisor for Global Technology Co., Ltd.
Published 30+ peer‑reviewed articles on peptide synthesis, author of the “Peptide Manufacturing Handbook” (3rd ed., 2024), and regular speaker at the International Society for Peptide Science (ISPS) conferences.
Contact: service@huanqiukeji9.com | Tel: +86 199 4383 0844
Global Technology Co., Ltd | No. 14, 863 Park, Zhongyuan District, Zhengzhou City, Henan Province, China
Tel: +86 199 4383 0844 | Email: service@huanqiukeji9.com
© 2026 Global Technology Co., Ltd. All rights reserved.
5. Trusted By Leading Research Institutes
Compliance & Certifications: CE, FDA, ISO 9001, GMP, RoHS, VDE, GS, CB, HACCP, IPPC. All certificates are downloadable from our secure portal upon order confirmation.
Join Our Trusted Network →